TSX:APS • CA03835T4081
Past quarterly earnings results for APTOSE BIOSCIENCES INC (APS.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | -1.34 | -10.71 | 87.52% | 96.91% | - | - | ||
| Q3 2024 | -11.10 | -36.41 | 69.52% | 78.98% | - | - | ||
| Q2 2024 | -12.90 | -36.11 | 64.27% | 81.06% | - | - | ||
| Q1 2024 | -21.90 | -22.64 | 3.29% | 67.56% | - | - | ||
| Q4 2023 | -43.20 | -48.81 | 11.49% | 12.73% | - | - | ||
| Q3 2023 | -52.80 | -62.86 | 16.01% | -6.67% | - | - | ||
| Q2 2023 | -68.10 | -61.64 | -10.49% | -37.58% | - | - | ||
| Q1 2023 | -67.50 | -53.55 | -26.05% | -25.00% | - | - | ||
| Q4 2022 | -49.50 | -49.83 | 0.67% | 59.26% | - | - | ||
| Q3 2022 | -49.50 | -55.74 | 11.19% | 15.38% | - | - | ||
| Q2 2022 | -49.50 | -61.64 | 19.69% | 26.67% | - | - | ||
| Q1 2022 | -54.00 | -71.15 | 24.10% | 33.33% | - | - | ||
| Q4 2021 | -121.50 | -78.69 | -54.41% | -68.75% | - | - | ||
| Q3 2021 | -58.50 | -76.72 | 23.75% | 13.33% | - | - | ||
| Q2 2021 | -67.50 | -85.49 | 21.04% | 28.57% | - | - | ||
| Q1 2021 | -81.00 | -78.60 | -3.05% | -20.00% | - | - | ||
| Q4 2020 | -72.00 | -77.46 | 7.04% | - | - | - | ||
| Q3 2020 | -67.50 | -79.75 | 15.36% | - | - | - | ||
| Q2 2020 | -94.50 | -66.88 | -41.30% | - | - | - | ||
| Q1 2020 | -67.50 | -48.20 | -40.06% | - | - | - |
Notes
APTOSE BIOSCIENCES INC (APS.CA) last reported earnings on 11/13/2025.
APTOSE BIOSCIENCES INC (APS.CA) beat EPS estimates and missed revenue estimates in the most recent quarter.